Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Fimasartan/Amlodipine FDC vs Co-administration in Healthy Volunteers
NCT02920047Phase 1Completed
- Sponsor
- Boryung
- Start
- Oct 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of fimasartan and amlodipine in hypertension (HTN) (3 arms), sponsored by Boryung. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve to the Last Measurable Concentration. Started Oct 2016; status: completed.
02
Drugs
fimasartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02920047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02920047.